TU-AB-BRA-10: Prognostic Value of Intra-Radiation Treatment FDG-PET and CT Imaging Features in Locally Advanced Head and Neck Cancer

2015 ◽  
Vol 42 (6Part31) ◽  
pp. 3588-3589
Author(s):  
J Song ◽  
Y Cui ◽  
E Pollom ◽  
B Durkee ◽  
S Aggarwal ◽  
...  
2007 ◽  
Vol 82 ◽  
pp. S41
Author(s):  
P. Dirix ◽  
L. Plessers ◽  
F. Slagmolen ◽  
S. Stroobants ◽  
W. Van den Bogaert ◽  
...  

2014 ◽  
Vol 17 (2) ◽  
pp. 139-144 ◽  
Author(s):  
F. Arias ◽  
V. Chicata ◽  
M. J. García-Velloso ◽  
G. Asín ◽  
M. Uzcanga ◽  
...  

2011 ◽  
Vol 29 (4) ◽  
pp. 243 ◽  
Author(s):  
Giwon Kim ◽  
Yeon Sil Kim ◽  
Eun Ji Han ◽  
Ie Ryung Yoo ◽  
Jin-Ho Song ◽  
...  

2018 ◽  
Vol 127 ◽  
pp. S625
Author(s):  
R. Carmona-Vigo ◽  
J.M. Blanco Suárez ◽  
M. Lloret Sáez-Bravo ◽  
P.C. Lara Jiménez

Oral Oncology ◽  
2010 ◽  
Vol 46 (5) ◽  
pp. e29-e33 ◽  
Author(s):  
Jen-Tsun Lin ◽  
Tung-Hao Chang ◽  
Cheng-Shong Chang ◽  
Wen-Hong Wang ◽  
Bi-Wen Su ◽  
...  

2019 ◽  
Vol 130 ◽  
pp. 10-17 ◽  
Author(s):  
Stefan Leger ◽  
Alex Zwanenburg ◽  
Karoline Pilz ◽  
Sebastian Zschaeck ◽  
Klaus Zöphel ◽  
...  

2017 ◽  
Vol 122 (12) ◽  
pp. 952-959 ◽  
Author(s):  
Rosario Mazzola ◽  
Pierpaolo Alongi ◽  
Francesco Ricchetti ◽  
Alba Fiorentino ◽  
Sergio Fersino ◽  
...  

Author(s):  
Federico Ampil ◽  
Michelle Norton

Abstract Aim: Little is known about how integrated positron emission tomography-computed tomography (IPET-CT), both imaging tools and not methods of treatment, contributes to head and neck cancer patients’ outcomes. We analysed the clinical PET-CT findings and their correlation to the effects of applied contemporary disease management. Methodology: A retrospective analysis of 29 individuals who underwent treatment planning fusion of PET-CT for radiochemotherapy of locally advanced head and neck cancer between 2010 and 2016 was undertaken. Gross tumour volumes were categorised as small (≤36 cm3) or large (>36 cm3), and tumour responses to therapy were classified as complete or incomplete. Results: The overall rates of complete tumour response (CTR), 3-year crude survival and failure (all types included) were 80%, 41% and 55%, respectively. Comparative analysis of tumour volume subsets revealed no significant differences in the rates of CTR (p > 0.80), 3-year survival (p > 0.30) and locoregional recurrence (p > 0.70). CTR was associated with improved prognosis (p > 0.05) and fewer tumour relapses (p < 0.02). Conclusion: Our findings, although not truly conclusive, appear in line with those in the literature. Smaller tumour volumes and CTRs shown on integrated PET-CT are likely to play important roles in the promotion of better prognosis, but further study with larger patient numbers and more data are needed.


Sign in / Sign up

Export Citation Format

Share Document